C12N 2795/00041
Use of virus, viral particle or viral elements as a vector
C12N2795/00041 (Use of virus, viral particle or viral elements as a vector) appears on 73 US grants and 122 published applications in this corpus.
Search patents in C12N- Granted patents
- 73
- Published applications
- 122
- Assignees
- 62
- Inventors
- 194
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 5 |
| 2011 | 0 | 6 |
| 2012 | 1 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 3 |
| 2015 | 6 | 1 |
| 2016 | 3 | 7 |
| 2017 | 3 | 7 |
| 2018 | 3 | 4 |
| 2019 | 7 | 14 |
| 2020 | 4 | 6 |
| 2021 | 6 | 9 |
| 2022 | 5 | 18 |
| 2023 | 10 | 15 |
| 2024 | 10 | 9 |
| 2025 | 5 | 2 |
| 2026 | 2 | 6 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/00043Viral genome or elements thereof as genetic vectorIndexing code55
- C12N 2795/00042Virus or viral particle as vehicleIndexing code9
- C12N 2795/00044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code6
- C12N 2795/00045Special targeting system for viral vectorsIndexing code6
Recent patents
- Bactericidal phage vectors26 May 2026US 12,637,681 B2Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Method of producing transduction particles20 Jan 2026US 12,528,842 B2SNIPR Biome ApS
- Methods of host cell modification26 Aug 2025US 12,398,380 B2Glaxosmithkline Biologicals SA
- Negative selection and stringency modulation in continuous evolution systems26 Aug 2025US 12,398,390 B2President and Fellows of Harvard College
- Targeted genome modification using circular single-stranded DNA1 Jul 2025US 12,344,858 B2Full Circles Therapeutics, Inc.
- Systems for modulating microbiome target cells, methods and compositions thereof16 Jul 2026US 2026/0199403 A1Trobix Bio Ltd.
- Method of producing transduction particles25 Jun 2026US 2026/0176308 A1SNIPR Biome ApS
- Attenuation of cytokine release syndrome in immunotherapy18 Jun 2026US 2026/0166069 A1Microcrispr Pvt Ltd.
- Targeted genome modification using circular single-stranded dna28 May 2026US 2026/0146261 A1Full Circles Therapeutics, Inc.
- Phage and Its Use in Compensating Soil Nitrogen Fixation22 Jan 2026US 2026/0022297 A1Institute of Soil Science, Chinese Academy of Sciences
Most cited
By later US patents
- Methods and compositions for genomic modification109US 6,632,672 B2The Board of Trustees of the Leland Stanford Junior University · 2003
- Evolution of site-specific recombinases66US 10,392,674 B2President and Fellows of Harvard College · 2019
- Negative selection and stringency modulation in continuous evolution systems64US 10,179,911 B2President and Fellows of Harvard College · 2019
- Multi-chain eukaryotic display vectors and uses thereof27US 9,034,601 B2Dyax Corp. · 2015
- Multi-chain eukaryotic display vectors and uses thereof18US 9,005,927 B2Dyax Corp. · 2015